IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors-Reference-Cited by-同舟云学术

IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors

Published:2011-12-01 Issue:12 Volume:121 Page:4746-4757
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Kerkar Sid P.,Goldszmid Romina S.,Muranski Pawel,Chinnasamy Dhanalakshmi,Yu Zhiya,Reger Robert N.,Leonardi Anthony J.,Morgan Richard A.,Wang Ena,Marincola Francesco M.,Trinchieri Giorgio,Rosenberg Steven A.,Restifo Nicholas P.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference58 articles.

1. Inflammation and cancer

2. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

3. Hallmarks of Cancer: The Next Generation

4. Macrophages, innate immunity and cancer: balance, tolerance, and diversity

5. Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

Cited by 284 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity;Frontiers in Immunology;2024-09-03

2. The dual nature of T_DC – bridging dendritic and T cells in immunity;FEBS Letters;2024-08-08

3. Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy;Translational Medicine Communications;2024-05-14

4. Short-term, nonsurgical periodontal therapy boosts interleukin-12 levels and reduces oral cancer risk;Irish Journal of Medical Science (1971 -);2024-05-03

5. State of the art and perspectives of CAR-T cell therapy for neuroblastoma;Cytotherapy;2024-05